Literature DB >> 9155638

Increased adjuvant efficacy in stimulation of antibody responses after macrophage elimination in vivo.

P P Leenaars1, H F Savelkoul, C F Hendriksen, N Van Rooijen, E Claassen.   

Abstract

To investigate whether macrophages influence the efficacy of adjuvants, we locally eliminated lymph node macrophages with dichloromethylene diphosphonate containing-liposomes before primary immunization. After macrophage elimination, animals were immunized with a soluble antigen (TNP-KLH; 2,4,6-trinitrophenyl-keyhole limpet haemocyanin) either in phosphate-buffered saline (PBS), in complete Freund's adjuvant (CFA), or in Specol is a water-in-oil emulsion, considered to be less aggressive than CFA, but equally effective. A secondary immunization followed with TNP-KLH. In vivo macrophage elimination before Specol/TNP-KLH immunization resulted in increased adjuvant efficacy as measured by (primary) antibody responses. This suggests that the activity of Specol is not primarily mediated through macrophages but rather through other antigen-presenting cell types (e.g. dendritic cells, B cells, fibroblasts). The overall quality of produced antibodies, in terms of isotype distribution and affinity maturation, remained the same. After primary injection, CFA/TNP-KLH immunization resulted in significantly higher antibody responses in macrophage-depleted animals and antibody responses did not increase significantly after secondary immunization. However, a booster effect was found when macrophages were not eliminated before CFA/TNP-KLH immunization, suggesting that the presence of macrophages during the first weeks of the primary immune response is essential for the induction of an effective secondary response in CFA immunizations. In conclusion, macrophage depletion before immunization with a soluble T-cell-dependent antigen combined with Specol may enhance specific antibody responses without changing the isotype or affinity of the antibodies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155638      PMCID: PMC1456609          DOI: 10.1111/j.1365-2567.1997.00337.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Vaccines: recent trends and progress.

Authors:  A C Allison; G Gregoriadis
Journal:  Immunol Today       Date:  1990-12

2.  A retrospective review of lesions associated with the use of Freund's adjuvant.

Authors:  J R Broderson
Journal:  Lab Anim Sci       Date:  1989-09

3.  Effects of chronic injection of sphingomyelin-containing liposomes on lymphoid and non-lymphoid cells in the spleen. Transient suppression of marginal zone macrophages.

Authors:  E Claassen; Y Westerhof; B Versluis; N Kors; M Schellekens; N van Rooijen
Journal:  Br J Exp Pathol       Date:  1988-12

4.  Comparison of adjuvants for immune potentiating properties and side effects in mice.

Authors:  P P Leenaars; C F Hendriksen; M A Koedam; I Claassen; E Claassen
Journal:  Vet Immunol Immunopathol       Date:  1995-09       Impact factor: 2.046

5.  Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies.

Authors:  J S Kenney; B W Hughes; M P Masada; A C Allison
Journal:  J Immunol Methods       Date:  1989-07-26       Impact factor: 2.303

6.  Regulation of isotype immunoglobulin production by adjuvants in vivo.

Authors:  E E Karagouni; L Hadjipetrou-Kourounakis
Journal:  Scand J Immunol       Date:  1990-06       Impact factor: 3.487

7.  Repopulation of macrophages in popliteal lymph nodes of mice after liposome-mediated depletion.

Authors:  F G Delemarre; N Kors; G Kraal; N van Rooijen
Journal:  J Leukoc Biol       Date:  1990-03       Impact factor: 4.962

8.  An evaluation of distress following intraperitoneal immunization with Freund's adjuvant in mice.

Authors:  L A Toth; A W Dunlap; G A Olson; J R Hessler
Journal:  Lab Anim Sci       Date:  1989-03

9.  Immunomodulation with liposomes: the immune response elicited by liposomes with entrapped dichloromethylene-diphosphonate and surface-associated antigen or hapten.

Authors:  E Claassen; N Kors; N van Rooijen
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

10.  Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody.

Authors:  G Kraal; M Breel; M Janse; G Bruin
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  2 in total

1.  Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen, II. Cellular, but not humoral, systemic immune responses against rabies virus immune-stimulating complexes are macrophage dependent.

Authors:  I J Claassen; A D Osterhaus; M Poelen; N Van Rooijen; E Claassen
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

2.  Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.

Authors:  Guillaume Goyette-Desjardins; Cynthia Calzas; Tze Chieh Shiao; Axel Neubauer; Jennifer Kempker; René Roy; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.